84/2008 Sb.
DECREE
of 26 March. February 2008
on good laboratory practice, detailed the conditions of treatment with drugs in
pharmacies, medical devices and for other operators and
devices producing medicines
Change: 254/Sb.
The Ministry of health and Ministry of agriculture lays down pursuant to §
paragraph 114. 2 and to implement section 2 (2). 2 (a). (c)), § 5 para. 4, § 8 para.
1, § 39 para. 3, § 77 para. 5 (b). (b)), § 79 paragraph 2. 1 (b). (c)), section 79
paragraph. 2 and 8 (b). a) and (c)), § 79 paragraph 2. 10, § 82 para. 1 and 3 (b). b), §
paragraph 82. 4, § 83 para. 1 and 3, § 83 para. 5 (b). (b)), § 84 paragraph. 3 and §
paragraph 85. 1 of law No 378/2007 Coll., on pharmaceuticals and on changes of some
related laws (law on medicinal products):
PART THE FIRST
INTRODUCTORY PROVISIONS
§ 1
According to this order are the procedures for the preparation, modification, storage,
receiving and dispensing of medicinal products in the pharmacy, at the workplace, nuclear
medicine with immunological, microbiological or workplace, in
devices to protect public health and to deal with the active
preparations in the provision of health services and health care.
§ 2
For the purposes of this Ordinance, means the
and individual preparation preparation of) a medicinal product for an individual
the patient according to the rules specified in § 79 of the law on pharmaceuticals,
(b) preparation of an intermediate mail preparation) intended to further
processing on the same healthcare providers or final
product a medicinal product without a prescription
prescribed for a particular patient or a particular animal,
(c) a radiopharmaceutical prepared radiopharmaceutical) such that
ready for a patient or group of patients to a specific
the examination,
(d)) activity of the forthcoming radiopharmaceuticals the amount of activity in medicine
of the given date and time,
e) standard operating procedure document which sets the repeating
activities,
f) pharmaceutical form of the medicinal product the technological processing of medicinal
substances and Excipients, characterised by the shape, composition and physical
structure, having regard to the physical structure of the formulations to be broken down to
formulation of solid, semi-solid and liquid, having regard to the shape is divided into
formulation of split and nonsplit; a detailed breakdown of the pharmaceutical form is the
contained in annex 1 to this notice.
PART TWO
THE RIGHT OF PHARMACEUTICAL PRACTICE AND THE MORE DETAILED CONDITIONS FOR OPERATION OF PHARMACIES
§ 3
Principles for the preparation of medicinal products
(1) for the preparation of medicinal products are used
and) of the active substance and excipients listed in the Czech Pharmacopoeia ^ 1) or in the
the list of active substances and excipients ^ 2) with proof of
quality ^ 3) (hereinafter referred to as the "certificate"),
(b) authorised medicinal products) ^ 4), which is not the way to use
listed in the approved summary of product characteristics, only if
If it is not present on the market a medicinal product that allows dosage
indicated on the recipe prescribed by a doctor
(c) enabling the accuracy of the weight in grams) active substances and excipients of
one order of magnitude higher than navažované quantity
(d)), the working items, tools, instruments, devices and packaging, made
from materials that do not affect the properties of the medicinal products.
(2) in the preparation of medicinal products
and all documents) so that it can be detected
the procedure for preparation and evaluation of quality; If the documentation is kept
electronically, the data is backed up soft
(b)), you cannot use the active substances and Excipients, after the expiry of their
application, or if there are deficiencies in them when
organoleptic inspection
(c)) shall be applied so as to exclude the possibility of confusion,
(d) a health professional) ^ 5) cannot be prepared at the same time more
various medicinal products,
e) cannot be used triturace, which means the well spread a mixture of medicinal
substances with other ingredient, usually with evinced resistance, or a solution of the drug substance with
the other ingredient, allowing for accurate weighing, the ratio of the active substance,
If it contains venena ^ 1), narcotic drugs or psychotropic substances
not operator control laboratories ^ 6) or pharmacy performed
review of identity and the content of these substances,
(f)) of the device which can affect the quality of the finished medicinal product
the product, regularly cleaned and checked.
(3) ^ 1) purified water can be stored at a temperature of not more than 25th. (C) and
use it for preparing medicinal products for a maximum period of 24 hours from the
her training; If after preparation, stored at 2-8th. (C),
You can use it for a maximum period of 72 hours. Longer can be
admit it, if it is accompanied by the stability studies. Purified water
held by in a closed system equipment for the preparation of purified water can be
used for the preparation of medicinal products at the time determined on the
the basis of the validation process.
(4) water for injections in airtight packages can be held by the
the preparation of medicinal products, the use for a maximum period of 24 hours from the time of
violation of the integrity of the packaging. However, if used as a water purified and
stored at 2-8th. (C), you can use it for a maximum period of 72
hours.
(5) the sterile medicinal products are prepared on the premises with prescribed
by the purity of the air, which should be periodically inspected; class of cleanliness
air are listed in Appendix 2 of this order.
(6) in the preparation of parenteral medicinal products group of anti-cancer agents
shall comply with requirements established for the preparation of sterile medicinal
preparations and requirements based on the specific nature of the active substances.
(7) in the preparation of radiopharmaceuticals shall comply with the requirements for working with
Open radionuklidovými the radiator under another law ^ 7).
(8) in the preparation of medicinal products, in addition to the procedures referred to in section 5 to
7 considers whether or not
and deliberation, weighing)
b) filling, packaging,
(c)) the distribution of individual packages of authorised medicinal products
for providers of health services,
d) scheme, which was disproportionately difficult or hazardous, in particular
Edit
1. radiopharmaceuticals,
2. injectable anti-cancer agents,
3. medicinal products for gene therapy,
4. medicinal products intended for parenteral nutrition.
§ 4
The editing policy of medicinal products
(1) for the adjustment of the medicinal product is considered to be the dilution of registered
medicinal products other than those referred to in § 3 (1). 8 (a). (d)), dissolving or
dilution of syrups, powder for the preparation of injectable products and adding
injectable solutions into infusion when they are performed in the containers intended for
this purpose, or in the case of sterile medicinal products using
medical devices guaranteeing the sterility.
(2) the authorised medicinal products can be edited only the procedures that
are in accordance with the summary of product characteristics ^ 8), in the case of
ance ^ 9) according to the manufacturer, under the conditions
set out the specific therapeutic program ^ 10) or, under the conditions
approved for the conduct of the trial ^ 11). In the case of the use of
medicinal product pursuant to section 8 (2). 3 (b). (b) point 1 of the law) on pharmaceuticals,
It can be edited under the conditions given by the manufacturer, as foreign
Summary of product characteristics. In the case of the use of the medicinal product in accordance with §
8 (2). 3 (b). (b) point 2 of the Act) on pharmaceuticals, it can be edited by
the manufacturer's instructions included in the documentation accompanying the medicinal product
for advanced therapy medicinal products.
(3) when using the purified water and water for injections for the adjustment of the medicinal
of the process according to § 3 (2). 3 and 4 apply mutatis mutandis.
§ 5
Preparation of sterile medicinal products
Preparation of sterile medicinal products
and sterile material of parenteral) technology, which eliminates the
biological, microbiological, chemical or physical contamination,
performed in the workspace class of purity of the air and that is located
the purity of the air in the airspace of class C,
(b)) shall be conducted in the area of parenteral class cleanliness C;
sterility requirement ensures thermal or microbial filtration in
the workspace cleanliness and class; in the same way
prepare other sterile medicinal products without additives, antimicrobial medications for regular
(c)) with the addition of antimicrobial medications for regular is topped by a microbial filtration and
rozplňováním in the workspace cleanliness and class or in
If the nature of the medicinal product makes it possible, followed by heat
sterilization,
(d)) that cannot be sterilized, takes place in the airspace of class
the purity of the air and that is located in the area of air purity class C;
for their preparation shall apply sterile active substances and Excipients,
e) containing cytotoxic compounds shall be carried out in a vacuum
Security boxes with vertical laminar flow class of purity
air and exhaust and outside space, which are located in the airspace of class
the purity of the air (C) and are reserved for this purpose,
(f)) for gene therapy is done in a vacuum of security boxes
with vertical laminar flow class with the purity of the air and and with take-off
outside the premises, which are located in the area of air purity class B and
are reserved for this purpose.
§ 6
Individual preparation
(1) if the maximum dose of active substances provided for in the Czech
Pharmacopoeia ^ 1) or therapeutic dose, maximum dose is not
fixed, and this is not a prescriber providing
health care or a veterinarian duly stamped and is not meant to
verify this information with the appropriate prescriber, pharmacist adjusts
quantity or concentration prescribed therapeutically active substance on
the usual ^ 1), change be indicated on medical prescription and confirm it with your
signature. Appropriate prescribing physician about this change, pharmacist
shall inform without delay.
(2) if the medicinal product prepared according to prescription
According to the knowledge and experience did not meet the quality requirements, the pharmacist
safety and efficacy, in particular when the prescribed medicine
contains substances incompatible or such, which are known to be
can negatively affect each other, the pharmacist will modify the medical
Act within the meaning of the qualitative or quantitative changes of the auxiliary
substances or medicinal substances. This change be indicated on medical prescription,
confirm it by his signature and the medicinal product shall prepare and, acting in accordance with the
made the change. In the case of changes to the active substances shall be made after this change
the previous agreement with the prescriber providing health care
or veterinarian.
(3) if it is possible to improve the properties of the medicinal product, using the appropriate
excipients, the pharmacist may perform a composition adjustment
of the product. The change indicated on medical prescription, shall acknowledge his signature and
medicine prepares and issues in accordance with the change.
§ 7
Mail preparation
(1) Mail preparation is carried out according to the process, which
means the progress of the preparations and prescribing documentation controls
of the product,
and) to 20 packs of the finished product a medicinal product pursuant to section 3, 5 and 6
and according to § 9 para. 1 and 2,
(b)) over 20 packs of the final product of the medicinal product, in batches according to the
§ 3, 5 and 6 in accordance with § 9 para. 3,
c) over 20 packs of the final product of the medicinal product, in batches according to the
§ 3 para. 8 (a). and (c))) and with the procedure laid down in point (a)),
d) drawn up for the intermediate.
(2) No process shall be carried out in accordance with § 2 mail preparation
(a). (b)), if it does not occur repeatedly.
§ 8
Labelling of active substances, excipients and pharmaceutical substances
(1) the packaging in which shall be kept for the active substances and Excipients,
shall be made unless it is marked directly on the cover firmly lpícím the label,
and a diagonal blue stripe) from the lower left to the upper right corner of the label
in the case of narcotic drugs and psychotropic substances ^ 12)
(b)) in white on a black label with venen,
c) red lettering on a white label on the separand,
d) black letters on a white label in cases not referred to in subparagraphs)
(c)),
(e)) in addition to the markings referred to in points (a) to (d))) a warning text
"Flammability" active substances and excipients flammable flammable and
"Corrosive" for the active substances and Excipients, corrosive corrosive.
If it is not a trade or the original packaging, is part of the
marking certificate number and lot number.
(2) Prepared medicinal products intended to supply to indicate
and white label), in the case of medicinal products intended for use by mouth,
the absorption of the mucous membranes of the oral cavity or injection,
(b)) a red label with the inscription "euthol", in the case of other
applications,
c) in the case of medicinal products intended for animals, according to subparagraph (a)), or
(b)) and a green label with the words "only for animals!"
(d) the address of the pharmacy); If the medicinal product issued another pharmacy than
the one that it has prepared, also marks the address issuing the pharmacy,
(e) the date of preparation and) if the shelf life is shorter than 48
hours, even an hour of preparation,
f) signature of the person who prepared the medicinal product, in the case of the preparation of the
According to § 6 and 7 (2). 1 (b). and § 7 (1)). 2,
(g)) of a batch of a medicinal product, in the case of preparation pursuant to § 7 para. 1 (b).
(b)), and (c)),
h) expiry date of the medicine, which means the length of time
in compliance with the prescribed method of storage of the medicinal product
retains its declared properties or properties needed for
intended use, its retention and an instruction manual, which
contains, in particular, how to use and dosage of the medicinal product, if
having regard to the nature of the medicinal product must be indicated,
I) used antimicrobial medications for regular, if ingredient when preparing added;
the eye preparations without antimicrobial medications for regular ingredients shall be marked with the symbol
"SA"
(j)), "poison", if it is on medical prescription by the doctor providing the
health care or veterinary surgeon specifically stated,
the composition, or name), in the case of medicinal products
prepared pursuant to § 7 or medicinal products intended to issue, for
providers of health services or for veterinary surgeons,
l) the total quantities of the medicinal product, it is not the individual
preparation under section 6,
m) on behalf of, or with the names, last name, identification number
the patient-the insured person; If the identification number was not assigned, date
the birth of the patient and the words "cytotoxic", in the case of medicinal
products group of anti-cancer agents,
n), on behalf of, or with the names, last name, identification number
the patient-the insured person; If the identification number was not assigned, date
the birth of the patient and the words "gene therapy", in the case of medicinal products
the gene therapy
about) on behalf of, or with the names, last name, and identification number of the
the patient-the insured person; If you have not assigned identification number, date of
the birth of the patient, in the case of parenteral pharmaceuticals prescribed
for a particular patient,
p) says "fire hazard", in the case of medicinal products flammable ^ 13), and
the inscription "Corrosive", in the case of medicinal products, corrosive ^ 13).
If used, the outer packaging shall be at least the particulars referred to in points (c)), g),
h), (j)), k), (l)), m), n), o) and (p)).
(3) the designation of intermediate products of medicinal products includes
and the name or composition),
(b)) the degree of completion, if developed,
(c)) date of preparation,
(d)) the expiry date,
e) signature that wrote.
(4) the medicinal products that are edited and are intended to supply for the
providers of health services or for veterinarians, shall be
the name or composition, the data referred to in paragraph 2 (a). a) to (f)), h), (j)) l)
and p), if these data are no longer listed on the packaging of the adjusted
of the medicinal product, where appropriate, the particulars identifying the patient according to the
a prescription.
(5) the distribution of the individual packages of registered medicines
products, these products indicate the name, strength or concentration,
lot and expiry date, if such data are no longer on the packaging
listed; at termolabilních medicinal products shall indicate whether or not the conditions
their retention.
(6) the Reagents for laboratory use, prepared in the pharmacy are referred to
yellow label with the words "Zkoumadlo" and disinfection solutions Red
label with the inscription "solution for disinfection".
(7) the investigational medicinal products within the framework of a clinical trial (hereinafter referred to as
"investigational medicinal product") must be labelled with the supplied
by the contracting authority with information pursuant to § 19 of the good clinical
practice ^ 37). In the case that the investigational medicinal products are prepared or
before dispersing, the further information referred to in paragraph 2 (a).
d) to (f)), and (h)).
§ 9
Check when receiving, preparing and editing
(1) in the case of medicinal products prepared checks the issuing person
appearance, quantity, packaging and marking.
(2) in the case of medicinal products prepared in bulk to 20 Pack final
the product of the medicinal product, the person who checks the medicine
prepared, the certificate used active substances and Excipients and
the completeness of the documentation.
(3) in the case of medicinal products prepared in bulk in quantities over 20 packs
the final product of the medicinal product is made in the input, process
and according to the pre-established inspection documentation. After the release of
medicinal products prepared in batches with a sample of each batch
stores after the expiry date.
(4) in the case of medicinal products prepared by repeatedly on the requisition of their
preparation and inspection is carried out according to the process or by
the standard operating procedure for these cases by
under section 22.
(5) in the prepared pure water check is made
and) chemical and physico-chemical,
1. at least once every 2 months and
2. after each intervention into its preparation,
b) microbiological, and at least twice a year.
When you check the pure water the process according to the Czech Pharmacopoeia ^ 1).
(6) prior to the use of active substances and excipients shall be carried out for each
Pack the organoleptic test.
(7) after adjustment for medicinal products, a check is made in accordance with paragraph 1.
Of medicinal products
§ 10
(1) registered medicinal products shall be issued in accordance with the decision of the
registration ^ 2), and in particular with the summary of product characteristics. Part of the
the issue is to provide the information necessary for the proper and safe
the use of medicinal products issued and for their retention.
(2) in the pharmacy to collect and process information about suspected
serious or unexpected adverse reaction, and other facts of serious
for the health of the people related to the use of the medicinal product and
defects in the quality of medicinal products which are brought in connection with the
issue and this information shall be notified to the National Institute for
drug control.
(3) in the case of medicinal products issued by the patient on a prescription the pharmacist verifies the
before dispersing, indicated dosage and stamped application; When
issue
and) may suspend the release of medicinal products, if, in his
knowledge and experience in their application could be
the mutual influence of undue or damage to the health of the patient; This
the fact shall consult with the prescriber or health
the doctor and in the case of the medicinal products, unreachable
There is a risk of default ^ 15); any changes to the reason for refusing the
Notes on a recipe,
(b) the number of packages) issues of the medicinal product, expressed in words, if the
recipe number of packaging, given the conflict between the numeral and the verbal indication,
(c)) shall consult with the prescriber,
1. If, in the case of the prescription of a medicinal product shall pay, from the public
health insurance according to the law on public health insurance,
the conflict between the main diagnosis cited in the case required an increased
payment of the prescribed medicinal product and information about indications, this
a medicinal product referred to in the summary of product characteristics and the
the fact is not on the recipe indicated by the symbol "(!)"
2. If the word "(!)" in the case that the dosage is exceeded
the corresponding SPC or referred to in the Czech Republic
Pharmacopoeia,
(d)) is not provided the symbol "(!)" and the prescriber is unreachable,
1. in the case referred to in point (c)) point 1 of the prescribed medicinal
medicine,
2. shall be adjusted in the case referred to in point (c)), point 2 of the dosage
the corresponding SPC or referred to in the Czech Pharmacopoeia
and inform about the prescribing physician as soon as possible,
e) more than one package of one kind of the prescribed medicinal
of the product paid by the public health insurance under the law on
public health insurance shall issue such number of packages which corresponds to the
ensure the treatment of a patient for a period of three months, if the prescribed number of
packaging exceeds this limit.
(4) if the medicine prescribed by the international non-proprietary name
the recommended World Health Organization with an indication of the desired
pharmaceutical forms, strengths and quantities, the pharmacist shall issue the corresponding medicinal product
the product with the lowest payment for the patient. With the consent of the patient
the pharmacist can give a medicine which supplement is not the lowest.
(5) a pharmacist prescribed the medicinal product, in the absence of the recipe
and the signature of the prescribing physician),
(b)) identification of providers of health services, which was a recipe
exposed, cannot be completed and there is no danger of default,
(c)) the signature of the approved veterinarian and the identification of the person entitled
provide veterinary care, if the medicinal product specified
for the animal,
(d)) the name, or first and last name of the patient and cannot be supplemented, if
It's not about the prescription of a medicinal product in the case of risk of default
in the provision of health care to a patient who is in danger of death
or appears to be a serious health disorders,
(e) the patient's identification number)-the insured person and his health code
the insurance undertaking; If the identification number was not assigned, date of birth
the patient, and cannot be added to it, or
(f)) first and last name of the keeper, in the case of medicinal product
destined for a beast and cannot be added.
§ 11
(1) if it is not available at the pharmacy the prescribed medicine and its
the immediate issue is with regard to the health of the patient is necessary, it may
the pharmacist to issue other than the prescribed medicine in the case that
and with such a procedure) the patient agrees, and the medicine is the same as from
the efficiency and the safety and
(b)) the medicinal product contains the same active substance with the same path
Administration and in the same dosage form; This does not apply for investigational medicinal products
preparations; If the medicinal product contains different quantity of the active
substances per unit of weight, volume or dosage forms, the pharmacist will adjust
his dosage to match the dosage prescribed by your doctor.
(2) Nevyznačí to the prescriber that insists on the release of the prescribed
of the medicinal product, the pharmacist can make when the conditions referred to in paragraph 1
(a). a) and b) issue other than the prescribed medicine.
(3) if the pharmacist in accordance with paragraph 1 or 2, shall mark the recipe
issued by a medicinal product, including any changes in payment and dosage.
(4) Replace prescribed medicine for another medicinal product with the
another active substance with similar therapeutic effects or any other drug
the pharmacist can form only, provided that the patient agrees,
swap is approved prescriber and carried out substitution
be indicated on the recipe, including the dosage.
(5) when the supply of the medicinal product prescribed by the veterinarian,
proceed according to the provisions of paragraphs 2 to 4 apply mutatis mutandis.
§ 12
(1) a recipe, and the recipe from the recipe listing, on which to repeat the issue
prescribed medicinal product when dispensing must affix the
and pharmacy)
(b) the date of issue) prescribed the medicinal product,
(c) the signature of the issuing pharmacist); in the case of an electronic recipe
the signature of the issuing pharmacist is replaced by its advanced electronic
signature based on a qualified certificate in accordance with the law on
electronic signature ("electronic signature")
(d)) or "fee no selected" ^ 16).
(2) for the supply of medicinal products without a prescription with
by limiting ^ 17) a pharmacist shall verify whether the conditions are met, the restrictions
laid down in the decision on registration, identity of the person requesting checks
medicinal product and such a person shall provide the information necessary for the
safe use of the medicinal product.
(3) issue on electronic recipe issues a pharmacist dispense
the product solely on the basis of the identification of the character communicated to the patient
prescriber.
(4) after the supply of the medicinal product to an electronic recipe
the pharmacist shall be sent by the issuing central store of electronic
recipes ^ 18) electronically information about picking.
(5) in the case of the acquisition of the electronic statement of the recipe is followed
under another law ^ 19).
(6) the dispensing of medicinal products is not restricted by § 39 para. 5
the law on pharmaceuticals or is not subject to medical prescription, can be issued and
self-service way in the areas of Pharmacy laid down for that purpose,
as well as the shipping method.
section 13 of the
Records of dispensing
(1) with regard to the issue on the basis of an electronic recipe, issuing
the pharmacist shall make a record of keeping supply that contains
and putting the patient's identification number)-the insured person; If
been allocated identification number, date of birth of the patient,
(b)) code of the medicinal product given to the State Institute for drug control,
(c)) the amount of the medicinal product,
(d)), issue date,
(e) the identification of the issuing pharmacist) and the identity of the pharmacy, where he was
picking takes place.
(2) a record of the issue are created through the information system
the issuing pharmacist, is complemented by electronic identification signs
prescription and medicinal products issued on its basis so as to
possible in the central store of electronic recipes pair
electronic recipe to a record about the issue, and prescribed medicines
actually issued.
(3) a record of the issue is through the information system
the issuing pharmacist sent in the format of a standard Extensible
Markup Language-XML (hereinafter referred to as "markup language") to a central
electronic storage of recipes.
(4) the central repository shall send by return e-recipes
the information system of the issuing pharmacist acknowledgement of receipt,
processing and saving the record on the issue. Part of this confirmation is
the pairing with electronic recipe to a record about the issue, and
prescribed medicinal products is actually issued.
§ 14
To change the data in the record on the issue, sent to a central repository
electronic prescriptions
Changes to the information in the record about the issue, which has been confirmed by the adoption,
sent through the information system of the issuing pharmacist
a central repository of electronic recipes in markup format
of the language. To send changes to the data in the record about the issue, and how central
store electronic prescriptions § 13 para. 2 to 4 apply mutatis mutandis.
§ 15
The cancellation of the recording of the issue presented to the central store
electronic prescriptions
(1) record on the issue, sent to a central repository of electronic
recipes, the issuing pharmacist cancel
and in the event of new) facts unknown at the time of despatch,
(b) in the case of a bad copy of) a record of the issue presented to
a central repository of electronic prescriptions,
(c)) in another when necessary;
and at the same time ensure the download of a medicinal product from the patient.
(2) Discontinuing the record of issue referred to in paragraph 1 shall in the centralized repository
electronic prescriptions be abolished and it is possible to implement new
issue.
(3) cancellation of a record on the issue is sent through the information
the system of the issuing pharmacist central store of electronic
recipe markup language format, stating the reason for that is
a record of the issue dropped.
(4) the cancellation of a record on the issue is in a central repository
electronic stores in the form of mark picking recipes for the cancelled and
a central repository of electronic recipes will send the information immediately
the system of the issuing pharmacist a confirmation of the cancellation of a record
picking.
section 16 of the
Access to electronic prescriptions issued by a pharmacist and to those
electronic prescriptions on the basis of the medicinal products have been already
released
(1) a pharmacist through its information system accesses the
electronic prescriptions that are stored in a central repository of electronic
recipes using electronic identification marks referred to in the
the electronic prescription and electronic identification of medicinal
products that have been issued by the issuing pharmacist.
(2) Lékárníkmápřístup to electronic prescriptions,
a) on the basis of issued through the information system of the active
products, posted by their release the record to a central repository
electronic prescriptions, and has stored their electronic identification
characters,
(b)) to which he gave the patient electronic identification signs.
§ 17
Communication with a central electronic repository for pharmacist, recipes and
technical documentation to issue, on the basis of
electronic prescribing
(1) the pharmacy information system with a central electronic repository
recipes communicates through software communication adapter.
Electronic communication between the pharmacist and the hub
electronic prescriptions takes place in a secure manner, with the
and all data sent) central repository of electronic recipes
are signed by electronic signature,
(b)) all data received from the central store of electronic recipes
are signed by electronic signature,
(c)) the data or the communication channel is encrypted.
(2) each time you access the pharmacist to a central repository
electronic prescriptions is a repository to satisfy the his access permissions.
(3) a record of the issue, the change request, cancel the electronic prescription and
all other data are established and a central repository for advice
electronic prescriptions sent in the format of the markup language.
A central repository of electronic recipes always confirms the sending
hand receipt and store the data in this store.
(4) all communications and data transmitted between the pharmacist and the Central
electronic storage of recipes are recorded in the register of records
the inputs and the activities of the central store of electronic prescriptions (hereinafter referred to as
"the register"). In particular, shall be recorded in the register.
including the receipt of the request) sent data, identification of the consigning
pharmacist, date and time of receipt of the request, and any other needed
information related to the request,
b) send data from a central repository of electronic prescriptions,
identification of the pharmacist, the data being sent, the date and time of receipt of the request and
any other necessary information related to sending data.
(5) the technical documentation for the supply of medicinal products on the basis of
electronic recipe is published in electronic form in
the information resource of the State Institute for drug control, and it contains
and) format specification markup language interface all the necessary
documents for the prescription, including the definition of schemas for validation
documents in the format of a standard Extensible language-XSD and
documents for the validation of the format of the markup language,
(b) electronic identification marks) specification, including format,
(c)) detailed description of the communication with a central repository of electronic
recipes and adapter for communication,
d) specification of access security and traffic information
running a pharmacist and central repository of electronic prescriptions and
other necessary specifications.
(6) documentation in a central repository of electronic recipes records
for 5 years, which begins on the first day of the following
the calendar year after the calendar year in which it was to register in the
relation to this documentation made the first record. In relation to the
electronic prescriptions that have been exposed to him, has the documentation
in the central store of electronic prescriptions and patient access; for
electronic communication between the patient and the hub
electronic prescriptions, the provisions of paragraphs 1, 2 and 5 as appropriate.
§ 17a
The registry entry for medicinal products with restrictions
(1) where a medicinal product is to be delivered with the restriction, the pharmacist verifies whether the
the conditions for preparation or issue of such medicinal
of the product.
(2) verify the implementation of training or supply medicinal
of the medical prescription or medicinal product with the
content of cannabis for medicinal use does the pharmacist through
its information system in the registry for medicinal products with restrictions
so that the identification of the electronic character of the recipe with the prescribed
medicinal product. In the case of a medicinal product without a
Regulation with the limitation, the identification number of the insured person, unless the
public health insurance, the insured person's name, last name and date
the birth of natural persons.
(3) the pharmacist for access to the registry of medicinal products with a constraint
It uses the same login as for the communication with the Central
electronic storage of recipes. For communication with the registry for
preparations with the restrictions of section 13 to 16 shall apply mutatis mutandis. Through
the registry for the restricted medicines pharmacist turnover
communicated, whether the conditions for the preparation or medicinal
the product with the limitations.
(4) if the conditions for the realisation of a medicinal preparation
preparation of cannabis for medicinal use, the pharmacist shall take into
registry for medicinal products with a restriction to undertake the preparation of the record,
that contains the
and the prescribed cannabis for) the type of treatment used and its code according to
the legal rules relating to the conditions of issue and use of the prescription,
cannabis for medicinal use,
(b) the quantity of hemp) for therapeutic use in the upcoming medicine
of the product,
(c)) date of commencement of the preparation and
(d) the preparation of the pharmacist and) identification identify the Pharmacy where
preparation made.
(5) if the conditions for the realisation of the supply of the medicinal product
on medical prescription or medicinal product without a
Regulation with the restrictions, the pharmacist shall make to the registry for medicinal products
by limiting the record on the implementation issue according to § 13.
section 17b
Communication with the registry for a pharmacist to medicinal products with restrictions and
the technical documentation
(1) a pharmacist is communicating with the registry for medicinal products with restrictions
through software communication adapter. Electronic
communication between the pharmacist and the registry for medicinal products with restrictions
takes place in a secure manner, with the
and) all the data sent to the registry for medicinal products with restrictions
they are signed by a recognized electronic signature,
(b)) all data received from the registry for medicinal products with restrictions
they are signed by a recognized electronic signature and
(c)) the data or the communication channel is encrypted.
(2) every time you approach a pharmacist for medicines to the registry with
the registry is verified by its access permissions.
(3) communication pharmacist with the registry for medicinal products with restrictions
including all traffic data related to the issue of being in the format
markup language. Through the registry for medicinal products
by limiting the sending side is always confirmed receipt and store data.
(4) all communications and data transmitted between the pharmacist and the registry for
medicinal products with restrictions are recorded in the register of records
the inputs and the activities of the registry for medicinal products. This
the register contains
including the receipt of the request) sent data, identification of the consigning
pharmacist, date and time of receipt of the request, and any other needed
information related to the request,
b) send data from the registry for the restricted medicines, sent
data, date and time of data submission and any other necessary information
related to sending data and
(c) adoption of the report of the issuing pharmacist) about implementation issues, including
the data sent, in the case of preparation of a medicinal product containing cannabis
for the therapeutic use of reporting pharmacist start cooking, identification
consigning pharmacist, date and time of receipt of a report and, where appropriate, other
the necessary information related with the adoption of the Declaration.
(5) the technical documentation relating to the supply of medicinal products with the
limitations and the communication with the registry for medicinal products is restricted in
electronic format, published by the Institute in a manner allowing remote
access, and includes
and) format specification markup language interface all the necessary
the documents, including the definition of schemas for validation of documents in a format
standard Extensible language-XSD and for validation of documents
the format of the markup language,
(b)) a detailed description of the communication with the registry for medicinal products
restrictions and adapter for communication and
c) specification of the transmitted data and access security information
running the registry for pharmacist medicines with restrictions and additional
the necessary specifications.
section 18
Mail order picking
(1) mail order picking ^ 21) is ensured by suitable technical means and
in a way that will ensure the availability of information about mail order picking and
medicinal products to persons using mail order picking. Start and
implementation of mail order is subject to the issue by introducing and maintaining
system for the collection, processing and communication of information on
suspected serious or unexpected adverse reactions
preparations.
(2) a pharmacy to ensure mail order picking
and) is equipped with a means of communication to provide information
services,
(b)) provides the conditions of carriage according to the nature of the medicinal product and
circumstances, in particular the external temperatures, so that they are in accordance with the
the terms listed in the summary of product characteristics; in the event of contractual
ensure carriage of medicinal products in the other person's pharmacy in
Agreement shall negotiate the right to monitor compliance with the traffic for this person
conditions,
(c)) shall ensure that the documentation of the activities linked to the picking and shipping
the retention of this documentation in accordance with section 22.
(3) medicinal products, their prices and costs associated with
mail-dispersing ^ 22) contains at least the name of the medicinal product in accordance with
the decision on registration, including the code allocated to the State Institute for
drug control or the Institute for State control of veterinary
Biologicals and medicaments, strength and package size, farmakoterapeutickou
the group, the delivery terms.
(4) to ensure the mail order Pharmacy dispensing shall indicate in the notice ^ 23) name
pharmacies, including its address, the date of commencement of activities consisting in the
implementation of mail-order picking, or its termination or suspension.
In addition, the name, or name and last name of the pharmacist or
pharmaceutical Assistant providing information services, telephone
links to information services, including the address of the website.
(5) in the case of mail order supplying medicinal products abroad
It removes the foreign pharmacy marked medicinal products from a Distributor and
It is kept separate from other medicinal products.
§ 19
(1) the dispensing of medicinal products on the requisition confirming the person
requisition issued, where appropriate, the person in charge of the takeover, issued
of medicinal products by his signature. Provider of health services,
whose part is issuing a pharmacy, the standard operating
procedure to specify a different method of confirmation of the acceptance of medicinal products.
(2) for the transport of magistral formulae for gene
group therapy or medicinal products injectable anti-cancer agents
or authorised medicinal products group of anti-cancer agents can be
only used sealable means of transport, which is
protects against deterioration and the surrounding environment from pollution.
The means of transport must be marked with the warning "gene therapy" or
"Cytotoxic" according to medicinal products transported. Similarly,
proceeds in the case of other medicinal products affecting significantly
human health and the environment.
(3) any medicinal product prepared in a pharmacy that contain venena or
separanda, except medicinal products in which venena or
separanda used as antimicrobial medications for regular ingredient shall not be issued without
a prescription.
(4) the medicinal products shall be issued after the adjustment made to providers
health services in appropriate containers, having regard to the nature of the medicinal
of the product and type of treatment so as to not to compromise their quality.
section 20
Medicinal products containing narcotic drugs or psychotropic
the substance
(1) medicines containing narcotic drugs or psychotropic
substance ^ 12) shall not be issued without a prescription, or repeatedly on one
the recipe, if it is not a medicinal products which can be used, according to
the decision on registration, medical prescription or without
a prescription with a constraint.
(2) Medicinal preparations containing narcotic drugs or psychotropic
substance ^ 12) may, if they are issued on the requisition, take only a doctor,
veterinarian or health care professional designated for this purpose
a natural or legal person authorized to provide health
care ^ 5).
(3) the issue of medicines containing narcotic substances or
psychotropic substances ^ 12) proceed pursuant to section 10 and 11; by
are without prejudice to obligations laid down in other legislation ^ 24).
section 21
The storage of medicinal products, active substances and excipients
(1) the active substances and excipients shall be kept under the conditions laid down
by the manufacturer, the upcoming medicinal products shall be kept under conditions
established technological regulations or a person who is prepared,
and authorised medicinal products shall be kept in accordance with the terms of
listed in the summary of product characteristics, or according to the manufacturer's instructions.
Compliance with the temperature set for the storage of medicinal products,
active substances and excipients are continuously checked.
(2) medicinal products, active substances and excipients unsatisfactory
quality, after the time of their application, stored or
prepared for other than the prescribed conditions, obviously damaged or
unused, must be marked accordingly and kept at the Pharmacy
separately from other medicinal products, active substances and excipients
substances.
(3) in the case of downloading, the medicinal product of circulation at the request of Pharmacy
marketing authorisation holders and distributors provides
information about the progress of the download.
(4) the narcotic drugs and psychotropic substances ^ 12) must be maintained in accordance
with other legislation ^ 24). Active ingredients and auxiliary substances listed
between venena must be kept separate, lockable cupboards.
Separanda is retained in the Prep room drugs separately from other
medicinal products, active substances and excipients.
(5) the investigational medicinal products shall be kept under the conditions laid down
by the manufacturer or by the sponsor of the clinical trial; must be kept
separately from other medicinal products in a manner allowing to distinguish
medicinal products from individual clinical trials.
section 22
Documentation
(1) the activities in a pharmacy that is associated with the receipt and storage of medicinal
medicinal products, active substances and Excipients, preparation or treatment of
medicinal products, including their monitoring, and dispersing the healing
preparations must be documented, in paper or electronic
form. If the activities documented standard operating procedures
or technological regulations, exercise, in accordance with the following
documents.
(2) Documentation in a pharmacy make up
and records)
1. the acceptance of medicinal products, including their release and assigned codes
The State Institute for drug control, or the Institute for State control
Veterinary Biologicals and medicaments, medicinal substances, excipients and
medicinal products prepared in a different pharmacy; for such an acceptance test to
the taking of medicinal products from other pharmacies in pharmacy
the conditions laid down in § 82 para. 4 of the law on pharmaceuticals,
2. turbocharging of the active substances and Excipients,
3. sterilization and packaging of medicinal products, items and equipment,
4. check the received active substances and Excipients,
5. the preparation and control of medicinal products prepared in bulk, including
records for the release of each batch of medicinal products prepared
bulk over 20 packs; These records shall be signed by the head of a pharmacist or
a person authorized by,
6. check the prepared pure water and water for injection,
7. the prescribed inspection apparatus
8. prescribed check the space is determined by the purity of the air,
9. complaints, due to quality defects, withdrawals of medicinal products
out of circulation and information about suspected serious or unexpected adverse
effect and other facts relevant to the health of the people related
with the use of the medicinal product,
10. dispensing of medicinal products to providers of health care services on the
requisitions,
11. send electronic information to a central repository of electronic
recipes by picking the medicinal product on the electronic
recipe,
12. the provision of an authorised medicinal product other pharmacy at
the conditions laid down in § 82 para. 4 of the law on pharmaceuticals; These records
contain an indication of the lot of the medicinal product and of the allocation of the State code
Institute for drug control, or the Institute for State control
Veterinary Biologicals and medicaments,
13. check the integrity of the safety box for preparation of medicinal
preparations containing cytotoxic compounds; This check is performed
Once a week,
14. check the integrity of the safety box for preparation of medicinal
medicinal products for gene therapy and control of sanitation carried out after preparing
These medicinal products for an individual patient; This check is
performed once a week,
15. the temperature of the storage of medicinal products, active substances and excipients
substances,
(b)) offer authorised medicinal products for the purposes of mail order
the picking
(c) orders) and accompanying documents to the issue regards,
d) recipes for medicines fully paid for by the patient and to the active
preparations for the treatment of the animals,
e) technological regulations
f) standard operating procedures related to the preparation and control of
medicinal products, storage and dispensing of medicinal products, including
mail order picking, and for processing and transmission of information on suspect
the side effects,
g) evidence of narcotics and psychotropic substances ^ 24),
h) hygienic and sanitation regulations,
I) other documentation relating to the preparation and treatment of medicinal
products and operation of pharmacies, including regulations, work,
proof of education or persons handling medicines and the credentials to represent the
the head of the pharmacist by another pharmacist ^ 25),
j) recipes and requisitions on medicines containing narcotic substances and
psychotropic substances ^ 12)
k) inventory, receipt and issue of the medicinal products referred to in
the individual items it possible to distinguish the pharmaceutical form, the amount of
active substance contained per unit of weight, volume, or drive drug
the form and the size of the packaging of the medicinal product, for the authorised
products, including the code of the State Institute for drug control
or the Institute for State control of veterinary Biologicals and medicaments,
l) evidence regarding supply of the medicine without a prescription with
restrictions to identify the person to whom the medicine
issued; This evidence includes the name and surname of the person to whom the
the product is issued, the number assigned to the health insurance company, which is
by the insured person, or date of birth, if it is not insured, and a short record
the State of health of the person, that medicinal product was issued, including the
the record of the interview with him, which should be in the range
strictly necessary for the assessment of indications,
m) records associated with the replacement for the withdrawn medicinal products
to identify the medicinal product to replace with an indication of its
the code allocated to the State Institute for drug control, or the Institute for
State control of veterinary Biologicals and medicaments and lot number;
the evidence also includes a brief record of the reason for the download date
to perform an Exchange and a record of the submission withdrawn medicinal products
According to § 89 paragraph 1. 1 or 3 of the law on medicinal products.
(3) technological prescription dated and signed by the head of
pharmacist, or by an authorised another pharmacist ^ 25), contains a procedure
preparation of the medicinal product, its composition, including the quantity of the active substance
unit of weight or volume, the destination of the packaging material, method of
the description and conditions of storage, as well as the procedures for carrying out checks
preparation, including the extent of the checks, indicating the values, which has
be achieved, and shelf life. Technological measure continuously
updates, changes that you make are characterized by so as to preserve the original
the text dated and signed by the head of the pharmacist. On the technological
Regulation of the use of the surplus is characterized by its expiry date
and the signature of the head pharmacist. If the European Pharmacopoeia ^ 26)
or the Czech Pharmacopoeia contains the provisions relating to authorised
product or technological provision, these provisions in the
technological regulation into account. Technological prescription may be maintained
as well as in electronic form. In this case, the head of the pharmacist shall ensure
their regular updating.
(4) the dossier, whose registration is not governed by other legislation ^ 27),
including orders and the accompanying documents to the issue, with regards
kept for at least 5 years from the date of the last entry or
mail order picking.
(5) the documentation of investigational medicinal products at the drugstore make up
records records of receipt and issue of investigational medicinal products, including
records on the conditions of storage of investigational medicinal products.
PART THREE
PREPARATION OF RADIOPHARMACEUTICALS AND TRAFFIC CONDITIONS IN THE WORKPLACE
NUCLEAR MEDICINE
Article 23 of the
Principles for the preparation of radiopharmaceuticals
(1) in the preparation of radiopharmaceuticals shall comply with the principles of good laboratory
practice referred to in sections 3 to 6 and section 7 (b). and) adequately. Radiopharmaceuticals are
preparing for the workplace of the holder of the authorisation to management of resources
ionizing radiation under other legislation ^ 28).
(2) the Radiopharmaceutical is
and prepared according to technological regulations) or standard
operating procedures, in which the rules are taken into account for the handling of
with radioactive substances), ^ 7 ^ 27), and according to the
1. The Czech Pharmacopoeia,
2. summaries of product characteristics and package leaflet in the case
authorised medicinal products, or
3. the procedure approved in the context of a clinical trial,
(b) control and wit the) technological regulations or
standard operating procedures referred to in subparagraph (a)).
(3) If, in the preparation of radiopharmaceuticals shall apply the blood components or other
biological material removed from the patient, can be prepared
radiopharmaceuticals used only for the patient, from which it was made.
section 24
Workflows
(1) in the preparation of radiopharmaceuticals are no more different
radiopharmaceuticals in one place ^ 7). Preparation of radiopharmaceuticals when
recovery of components of blood or other biological material shall be made
on the space provided for this purpose only.
(2) if the prepared radiopharmaceutical transported, shall be
under another law ^ 29).
(3) the Radiopharmaceuticals, which have not been used, after the expiration of their
usability considered radioactive waste and is with them and according to
usage ^ 7).
§ 25
Labelling of radiopharmaceuticals
(1) the inner packaging of radiopharmaceuticals prepared before the release of marks
the label, which is given the name, the chemical symbol of the radionuclide,
the quantity in millilitres with total activity, the name or names and
last name that wrote the date and hour. In a similar manner and marks
the outer packaging. If the issuing the radiopharmaceutical in the syringe to
the individual patient, in his name, or the names of the first and last name
or otherwise unmistakable way.
(2) a radiopharmaceutical is attached to the pending passport, which in addition to
the data referred to in paragraph 1 also contains
a) method of administration,
(b)) the name, or first and last name of the person who carried out the inspection
the prepared radiopharmaceutical.
section 26
Documentation
(1) a workplace to provide Documentation of the radiopharmaceutical consists of
and records)
1. reception of radio-nuclide generators, radio-pharmaceuticals, or medicinal substances
and auxiliary substances,
2. the preparation of radiopharmaceuticals,
3. check the prepared radiopharmaceuticals,
4. the control of devices and equipment for the preparation and evaluation of the quality
radiopharmaceuticals,
5. the results of the monitoring of the workplace ^ 7),
6. the issue of radiopharmaceuticals,
7. management of radioactive waste ^ 7),
8. complaints due to defects in quality and the download of the medicinal
products from circulation,
(b) regulations or) technological standard operating procedures referred to in §
23 para. 2 (a). and (3))
(c)) evidence of radioactive materials ^ 7),
d) operating, sanitation and an internal emergency plan
.
(2) documentation of sites serving radiopharmaceuticals is included in the
paper or electronic form. If her evidence does not control other
^ Law 27), including orders, shall be kept for at least
period of 5 years from the date of the last entry.
section 27 of the
Review
(1) before issuing the radiopharmaceutical prepared to verify its quality according to §
23.
(2) to be checked, use the apparatus and equipment, whose eligibility
to measure has been verified under other legislation ^ 30).
(3) the site at which they prepare radiopharmaceuticals, monitors
under another law ^ 7).
section 28
Special provisions
(1) the premises and facilities for the preparation of radiopharmaceuticals governing other legal
^ 7) regulations.
(2) for the cleaning of premises and equipment in the workplace of radiopharmaceuticals,
processes a standard operating procedure, which includes the frequency
the individual sanitation work.
(3) in the event of radiological accident or incident shall
According to the internal emergency plan of the workplace, the instructions of the responsible
person ^ 31) and other legislation ^ 32).
PART FOUR
PREPARATION OF HUMAN VACCINES AND MORE AUTOGENNÍCH TERMS OF
WORKPLACES TAKING THEIR PREPARATION
section 29
Preparation and checking of vaccines for human autogenních
(1) in the preparation of human vaccines, the autogenních shall comply with the principles of
good laboratory practice referred to in § 3 to 7 as appropriate.
(2) Human autogenous vaccines are prepared on the basis of medical
prescription for an individual patient under the drawn up by technological
prescription. The responsible person ^ 31) is responsible for the observance of technological
How to prepare and is responsible for the quality, efficacy and safety
autogenous vaccines.
(3) as a raw material for the preparation of vaccines will be used for human autogenních
pathogens or antigens collected from the patient for whom it is
the vaccine is intended.
(4) in the case of vaccines for human autogenních check is made in accordance with § 9
adequately. The control of biological tests are carried out according to the nature and
the method of preparation of Autogenous vaccines and the technological
legislation.
section 30
Labelling and documentation
(1) in the labelling of human vaccines in addition to the requirements of the autogenních
referred to in § 8 para. 2 (a). (e)), f), (g)), h), k), (l)) and o) and § 8 para. 3
further indicating that human autogenous vaccine has prepared, and
the method of administration.
(2) Documentation in the workplace in preparation of human autogenous vaccines
make up the
and prescription)
(b)) record
1. collection,
2. your own preparation, including dilution,
3. check
4. storage and delivery,
5. periodic inspection according to § 3 (2). 2 (a). (f)),
c) standard operating procedures documenting
1. the collection,
2. control,
3. storage and picking
4. operational, hygiene and sanitary regulations,
(d) the rules of technology, documenting the preparation) of human autogenních
vaccines in accordance with § 22 para. 3.
(3) in the preparation of human vaccines, the autogenních, in addition to the activities
referred to in paragraph 2, the document and the activities associated with the collection of the
pathogens or antigens.
(4) the dossier is registered under section 22 by analogy.
PART FIVE
PICKING CONDITIONS IN THE INSTITUTIONS OF PUBLIC HEALTH
section 31
Dispensing of immunological products
(1) public health authorities issued immunologicals
(hereinafter referred to as "vaccines") for the purpose of vaccination of natural and legal persons
authorized to provide health care under another law ^ 33)
According to the annual plan of vaccines in the case of vaccines, with the exception of vaccines
rabies, tetanus when injuries and healing wounds, against
Tuberculosis and tuberculin ^ 34).
(2) the employee with professional qualification for working in health care in
authority to protect public health ^ 5)
and according to the annual plan) issues of vaccines provided for amount and type of vaccine
the basis of the order of natural or legal persons authorized to provide
health care,
(b)) at the time of verification of the quantities, type, package, batch number and time
the applicability of the vaccine; If the vaccine is not available in the requested
the size of the package, the other package size in the appropriate number of
the benefits and the change shall be recorded in the order; acknowledge his signature issue and
identification of the authority to protect public health,
(c) before issue of vaccine) checks whether the ready for shipment
packaging that ensure compliance with the temperature specified by the manufacturer; If they are not
These packages are ready, the vaccine will not issue.
(3) the employee of natural or legal persons authorized to provide
health care authorized to receive the vaccine the vaccine to its takeover confirmed
the signature on the original transcript and order.
§ 32
Storage of vaccines
The vaccine is kept under the conditions referred to in the summary of
the product, in accordance with the terms of the specific treatment programs
where appropriate, in accordance with the manufacturer's instructions. Compliance with the temperature is checked
the unit documenting compliance with a prescribed temperature range.
The provisions of § 21 para. 2 and 3 shall apply mutatis mutandis in the case of vaccines.
§ 33
Documentation of receipt, dispensing, and storage of vaccines
(1) the activity in the establishment of public health protection associated with dispersing,
reception and storage of vaccines, the documents. If the dossier is
conducted in electronic form, the data is backed up renewable way.
The documentation consists of
and records of taking delivery of the vaccines), including their lot and code,
(b)) order vaccines for the period presented by providers of
health services,
c) processed vaccines on a given period plans based on the demographic
the data of the relevant territorial unit, a valid vaccination schedule and
requirements for providers of health care services,
(d) records of the performed inspection) temperature range during storage
vaccines, and it at least once a day, and when transporting vaccines, with a
signature control performing employees
(e) the record of destruction) vaccines, including because of the destruction, the name,
where appropriate, the names and surname of the person who approved the destruction of species,
quantity, lot number and expiry date of the vaccine,
f) records for the complaints due to defects in quality or download the vaccine
out of circulation and information about suspected serious or unexpected adverse
effect and other facts relevant to the health of the people related
with the use of the medicinal product,
g) records of equipment,
h) inventory, receipt and issue of vaccines according to the individual
items possible to distinguish the pharmaceutical form, the quantity of the active substance
contained in the unit of mass, volume or unit dosage forms and
the size of the packaging of the vaccine, including code,
I) standard operating procedures for the receipt, distribution and storage of vaccines,
j) operational, hygiene and sanitary regulations.
(2) documentation is kept pursuant to section 26 paragraph 1. 2 accordingly.
PART SIX
CONDITIONS FOR THE HANDLING OF MEDICINAL PRODUCTS IN THE PROVISION OF HEALTH
SERVICES WITH THE EXCEPTION OF THE PROVISION OF PHARMACEUTICAL CARE
§ 34
Supply of medicinal products
The providers of health services supplied medicines pharmacy or
the operator of another workplace or equipment serving the healing
preparations. Blood transfusion products delivered to providers of health
device services transfusion services; gases used in the provision of
health services, advanced therapy medicinal products, rated
medicinal products, infusion, hemofiltrační and dialysis solutions and
immunological preparations for vaccination, they can be supplied also
wholesale distributors of medicinal products. Provider of health services
progresses in treatment with medicinal products, so as to ensure the
quality, safety and efficacy of medicinal products.
§ 35
Adjustment of the medicinal products
When you edit a medicinal health services provider is
proceed according to the summaries of the individual medicinal products,
the manufacturer or the contracting entity or clinical trials by
standard operating procedures, in which the conditions will apply
preparation in accordance with § 3 (1). 4 and 8, section 4, paragraph 4. 1, § 8 para. 4 and § 9 para. 7.
section 36
The retention of
(1) medicinal products shall be kept under the conditions referred to in summary
information about the product or the manufacturer's instructions, the supplying pharmacy or
workplace or equipment preparing medicinal products and shall apply
storage conditions pursuant to § 21, mutatis mutandis.
(2) any medicinal product prepared in a pharmacy shall be stored only in
original packaging.
(3) medicinal products shall be stored so as to preserve the data that
It identifies.
(4) the investigational medicinal products should be maintained according to the instructions of the manufacturer or
the sponsor of the clinical trial separately from other medicinal
preparations.
§ 37
Documentation
(1) activity associated with income, transportation, treatment, storage of medicinal
products and the use of medicinal products in the provision of health
services is documented. If the documentation is kept in electronic
the form, the data is backed up renewable way.
(2) Documentation form
and records)
1. reception of medicinal products,
2. the use and adjustment of the medicinal products in the provision of health
care,
3. the register of medicinal products in the workplace,
4. check the temperature of the storage of medicinal products, in the case of
medicinal products that require reduced temperature retention of records
carried out at least once a day,
5. complaints due to defects in quality and the download of the drug from circulation,
(b)) information about suspected serious or unexpected adverse reaction and
other facts relevant for the health of the people related to the
the use of the medicinal product,
c) standard operating procedures documenting to the extent appropriate
activities carried out by the
1. reception of medicinal products,
2. adjustment of the medicinal products,
3. use of medicinal products in the provision of health services,
including equipping patient medicines ^ 35),
4. the storage of medicinal products.
(3) the standard operating procedures are provided with the date and signature of the person,
that is in the selected site for the handling of medicinal products
responsible.
(4) the dossier is registered under section 22 by analogy.
§ 38
For the equipping of the patient ^ 35) may only be granted a medicine
and in the package) whose integrity is not impaired, or
(b) rigid or semi-rigid) split pharmaceutical forms; such a medicinal product
the product shall be provided, in the container tightly closed, on which shall be entered the name of the
of the medicinal product including strength and its manner of use and the conditions of its
the retention.
PART SEVEN
MEDICINAL PRODUCTS TO VETERINARIANS, RETENTION AND LEADERSHIP
DOCUMENTATION
§ 39
Issue
In the case that a veterinarian for treatment of the animal emits healing
preparations of animal breeders, performs a veterinarian and breeder,
which the medicinal product is released, the record on the issue. Veterinarian
instruct breeders about the dosage, mode of application and storage issued
of the medicinal product. For medicinal products which affect the behavior of
an animal or have set withdrawal period, and the time keeper will instruct
their duration and of the obligations that this entails.
section 40
The retention of
(1) the veterinarian shall keep the medicines in the manner specified in §
21, art. 1 to 3, even in transit, if the veterinarian
pursues a professional work outside of their doctor's Office.
(2) any medicinal product prepared in a pharmacy are kept only in the
original packaging.
(3) on the initiative of the Institute for State control of veterinary Biologicals and
of medicines, the marketing authorisation holders or distributors downloads
veterinarian medicines out of circulation in case of suspected
the occurrence of the adverse event or faults in the quality of the medicinal product. In
case of suspected quality defect for a medicinal product
the veterinarian shall inform the State Institute for drug control.
(4) medicines containing narcotic drugs or psychotropic
^ 12) substances shall be stored pursuant to § 21 para. 4.
§ 41
Documentation
(1) the activities associated with the collection and storage of medicinal, dispersing
medicines in veterinary surgeon, including their control, shall be
documented.
(2) Documentation form
and records)
1. acceptance of authorised medicinal products and medicinal products
prepared in the pharmacy,
2. complaints due to defects in quality and download drugs out of circulation and
information on the occurrence of a serious side effect of the medicinal product
or adverse reaction, which in the context of this
with a man, even in the case when this product
the product has not been used in accordance with the summary of product characteristics, the
used incorrectly or was misused,
3. dispensing of medicinal products farmers acquired in accordance with other legal
Regulation ^ 36),
4. check the storage condition of pharmaceuticals for veterinary surgeon,
(b)) evidence of narcotics and psychotropic substances ^ 12) according to another
^ Law 24),
c) blocks used recipes marked with a blue stripe and blocks used
requisitions marked blue stripe.
(3) documentation is kept in accordance with section 22 apply mutatis mutandis.
PART EIGHT
TRANSITIONAL AND FINAL PROVISIONS, THE CANCELLATION
§ 42
Transitional provision
For the active substances and Excipients, produced by the entry into force of this
the decree is carried out before applying them to each package in addition to the
an organoleptic examination pursuant to § 9 para. 6 as well as physico-chemical testing.
§ 43
Regulation (EEC)
Shall be repealed:
1. Decree No. 255/2003 Coll., which provides for the right of pharmaceutical
practice, more detailed conditions for the preparation and editing of the medicinal products, supply and
treatment with medicinal products in medical devices, and more
conditions for operation of pharmacies and other operators, of the issuing of the active
preparations.
2. Decree No. 220/2006 Coll., amending Decree No 255/2003 Coll.
laying down the right of pharmaceutical practice, more detailed conditions for the preparation and
adjustment of the medicinal products, supply and handling of medicinal products within the
medical facilities and further conditions of operation of pharmacies, and other
operators, of the issuing medicines.
3. Decree No. 6/2007 Coll., amending Decree No 255/2003 Coll.
laying down the right of pharmaceutical practice, more detailed conditions for the preparation and
adjustment of the medicinal products, supply and handling of medicinal products within the
medical facilities and further conditions of operation of pharmacies, and other
operators, of the issuing of medicinal products, as amended by Decree No.
220/2006 Sb.
§ 44
The effectiveness of the
This Decree shall take effect on the date of its publication.
Minister of health:
Mudr. Julínek, MBA in r.
Minister of agriculture:
Mgr. Gandalovič in r.
Annex 1
A DETAILED BREAKDOWN OF THE MEDICINAL FORMS WITH REGARD TO THE COMPOSITION AND THE ROUTE OF ADMINISTRATION
-------------------------------------------------- --------------------------------------------------------------------
The Latin name of a pharmaceutical formulation for detailed examples of medicinal products within the pharmaceutical forms
forms of
-------------------------------------------------- --------------------------------------------------------------------
Liquid and semi-solid Peroralia liquida et oral drops, oral solution, oral suspension,
oral preparations of semisolida oral emulsion, powder propřípravu oral solution
or suspension, granules for oral preparation
suspension, powder for oral solution, or
suspension with solvent, syrup, powder for syrup
granules for preparation of syrup, Tablet for the preparation
oral solution or suspension, medicinal tea, powdered
medicinal tea, oral gel oral paste,
Solid oral products Peroralia solida oral powder, effervescent powder, granules, sparkling spheres
powder enteric coated granules, granules
prolonged release granules with controlled
release, starch capsule, capsule, capsule, soft,
enteric coated capsule, enteric coated capsule, soft,
prodlouženýmuvolňováním capsule, hard, soft capsule
prolonged release, controlled release capsule, hard
release, soft capsule, Tablet, controlled-release tablets
coated tablet, film-coated tablet, effervescent tablet,
oral lyophilisate, gastro-resistant tablet, Tablet
modified-release tablets, prolonged-release tablet,
chewable tablet, oral gum, pill, intraruminální
the Insert for the pulse easing (vet), liz (vet), premix for
medicated feedingstuffs (vet), pellets
Oral preparations and Oromucosalia et Gargle, concentrate for gargles, powder for
preparations for use on the gingivalia preparation, for the preparation of Tablet gargles gargles, oral
gums, oral suspension, solution, oral drops, oral spray,
the sublingual spray, solution for oral rinses, tablets for
prepare the solution for oral rinses, solution on the gums, oral
gel oral paste, medicated chewing gums, gel, paste
on the gums, oral capsule, sublingual tablet, mukoadhesivní
bukání tablet, bukání tablet, lozenge
Dental preparations Stomatologica Dental gel, tooth bar, tooth powder, tooth, dental solution
suspension, emulsion, toothpaste dental
Preparations for skin and Dermatologica and an ingredient in baths, cream, gel, ointment, paste, skin mousse,
transdermal use transdermalia shampoo, skin spray solution, skin spray-suspension, skin
spray-powder, solution, concentrate for skin
the solution, skin, skin emulsion, suspension, skin powder, solution
for iontoforézu, a transdermal patch skin coating, healing
Nail Polish, kataplazmata, skin filled with stick
dressing means the collar (vet) medikovaný pendant
(vet), ear label (vet), soaking bath-solution (vet.)
soaking bath-suspension (vet.), soaking bath lotion
(vet), pouring on the back-the solution (vet.), pour-on
spine-emulsion (vet.), kapkyna skin-a solution or suspension
or emulsion (vet.), teat bath-soaking solution or
suspension or emulsion (vet.), spray on the teats-solution (vet.)
Eye preparations Ocularia eye cream, eye gel, eye ointment, eye drops, solution or
suspension, powder and solvent for the preparation of eye drops
in the solution, powder and solvent for the preparation of eye drops
in suspension, a solvent for the preparation of eye drops, eye
prolonged release drops, eye water, solvent for
preparation of the eye water, eye insert,
Ear preparations Auricularia Ear ear gel cream, ointment, ear, ear drops-the solution or
suspension or emulsion, ear, ear spray-powder solution or
suspension or emulsion, ear omývadlo-solution or emulsion,
ear swab, ear stick
Nasal products Nasal Nasalia cream, nasal gel, nosnímast, nasal drops-the solution or
suspension or emulsion, nasal, nasal spray-powder solution or
suspension or emulsion, nasal, nasal omývadlo rod
Vaginal preparations Vaginalia Vaginal cream, vaginal cream, vaginal, vaginal ointment
gel, vaginal foam, vaginal, vaginal suspension, solution
vaginal Tablet for preparing emulsion, vaginal solution,
vaginal ball, hard vaginal capsules, soft vaginal
Capsule, vaginal tablet, effervescent vaginal tablet, medicine
vaginal tampon, vaginal, vaginal insert hubka (vet.)
Rectal preparations Rectalia Rectal cream, rectal gel, rectal ointment, rectal foam,
rectal solution, rectal suspension, rectal emulsion,
concentrate for rectal solution of powder for
preparation of rectal solution, powder for rectal
suspension, Tablet for rectal solution preparation, Tablet
for the preparation of rectal suspension, suppository, rectal capsules,
rectal swab
Inhalanda inhaled medication nebuliser solution, suspension of spraying powder for
the suspension of spraying, emulsions for spraying,
inhalation solution tlakovémobalu, suspension for inhalation
in suspension, emulsion for inhalation glucocorticoid, powder
for inhalation, inhalation powder, hard capsules, inhalation powder
for inhalation, steam inhalation powder, solution
inhalation of steam, steam inhalation tablet,
ointment steam inhalation, inhalation fluid
steam, gas inhalation
Parenteral drug products Parenteralia solution for injection or the suspension or emulsion, powder for
solution for injection, powder for suspension or
solution for injection, powder for injection
injection solvent concentrate for
solution for injection, infusion, or emulsion,
powder for solution for infusion, powder for the preparation of
the infusion solution with the solvent, the solvent for
Parenteral use.
Implantata implants implant, implantation, implantation Tablet string
Preparations for dialysis Praeparata for dialysi Solution for peritoneal dialysis solution for hemofiltraci,
haemodialysis solution, concentrate for solution
for hemodialysis
Urethral and Uretralia et Solution into the bladder, the solution to rinse the urinary
preparations for use in intravesicalia bladder powder for přípravuroztoku to rinse of the urinary
bladder bladder, urethral gel, urethral Stamen
Tracheopulmonální Tracheopulmonaria a solution or suspension to endotracheopulmonální the installation,
products for the preparation of roztokuk powder endotracheopulmonální
installation, powder for solution
to install endotracheopulmonální with solvent
Endocervical Endocervicalia Endocervicální gel products, powder for the preparation of the endocervical
the solution with the solvent
Intramammary preparations Intramammaria (vet.) Intramammární a solution or suspension or emulsion, intramammární
(vet.) ointment, struková bar,
Intrauterine preparations Intrauteriaria (vet.) Intrauterine insert, intrautrinní solution, intrauterine
(vet.) suspension, intrauterine emulsion, intrauterine tablet,
intrautrerinní capsule
-------------------------------------------------- --------------------------------------------------------------------
Annex 2
CLASSIFICATION OF AIR CLEANLINESS FOR EACH CLASS BY THE NUMBER OF PARTICLES
+--------------------------------------------------- ---------------------------------------------+
| The maximum number of particles/m3 equal or greater |
| Class |
| For the rest (b) For traffic |
| |
| mikrom mikrom 0.5 0.5 5 mikrom 5 mikrom |
+--------------+-----------------+----------------+- ----------------------+----------------------+
| A | 3 520 | 20 | 3 520 | 20 |
+--------------+-----------------+----------------+- ----------------------+----------------------+
| | 3 520 | | | |
| (B) (a) | | 29 | 352 000 | 2 900 |
+--------------+-----------------+----------------+- ----------------------+----------------------+
| (C) (a) | 352 000 | 2 900 | 3 520 000 | 29 000 |
+--------------+-----------------+----------------+- ----------------------+----------------------+
| (D) (a) | 3 520 000 | 29 000 | undefined (c) | undefined (c) |
+--------------+-----------------+----------------+- ----------------------+----------------------+
Notes
(a) in order to achieve the requirements of the class, (B), (C) and (D), the air exchange rate
adapted to the size of the room, placed the device in it and the number of
workers in the room. Ventilation should be provided with the appropriate
filters, such as HEPA for classes A, B and C.
(b) the Limit for the maximum number of dust particles in an "idle"
corresponds to ISO classification, as follows:
Class, and corresponds to ISO 4.8 when the limit for particle size > = 5.0 mikrom,
class B corresponds to ISO 5. Class C corresponds to ISO or ISO 7 and 8 class
(D) corresponds to ISO 8.
(c) the requirements and limits for this class are dependent on the nature of
operations are carried out.
1) section 11 (b). d) of Act No. 378/2007 Coll., on pharmaceuticals and on changes
certain related laws (law on medicinal products).
2) section 11 (b). (b)) Law No 378/2007 Sb.
3) § 79 paragraph 2. 8 (a). and) Act No. 378/2007 Sb.
4) § 25 para. 1 of law No 378/2007 Sb.
5) Act No. 95/2004 Coll., on conditions for the acquisition and recognition of professional
competence and specialized competence to perform the medical
the professions of doctor, dentist and pharmacist, as amended by Act No.
125/2005 Sb.
Law No. 96/2004 Coll., on conditions for the acquisition and recognition of eligibility for
the exercise of paramedical professions and to pursue activities
related to the provision of health care and on amendments to certain
related laws (the law on the paramedical professions),
in the wording of later regulations.
6) section 69 of the Act No. 378/2007 Sb.
7) Decree No 307/2002 Coll., on radiation protection, as amended
regulations.
8) § 3 (1). 1 of law No 378/2007 Sb.
9) § 8 para. 3 of the law No 378/2007 Sb.
10) section 49 of Act No. 378/2007 Sb.
11) § 51 of Act No. 378/2007 Sb.
12) Annex 1 and 5 of the Act No. 167/1998 Coll., on substance abuse and
amendments to certain other laws, as amended.
13) Law No 350/2007 Coll., on chemical substances and chemical mixtures and
amending some laws (legislation).
14) section 39 of Act No. 378/2007 Sb.
15) Decree No. 54/2008 Coll., about how the prescription of medicinal
products, information to be entered on the medical prescription and the rules
the use of prescriptions.
16) Act No. 48/1997 Coll., on public health insurance and amending and
certain related laws, as amended by the Act No. 261/2007
SB.
Decree No. 54/2008 Sb.
17) § 39 para. 3 of the law No 378/2007 Sb.
18) § 82 para. 1 of law No 378/2007 Sb.
19) section 15 of Decree No. 54/2008 Sb.
21) section 84 and 85 of law No 378/2007 Sb.
22) § 85 para. 2 of law No 378/2007 Sb.
23) § 84 paragraph. 3 of the law No 378/2007 Sb.
24) Act No. 167/1998 Coll., as amended.
25) § 79 paragraph 2. 6 of law No 378/2007 Sb.
26) section 11 (b). (c)) Law No 378/2007 Sb.
27), for example, Act No. 18/1997 Coll. on peaceful uses of nuclear energy
and ionizing radiation (the Atomic Act), and amending and supplementing certain
laws, as amended, Act No. 258/2000 Coll., on the protection of
public health and amendment to some related laws, as amended by
amended.
28) Act No. 18/1997 Coll., as amended.
29) Law No 111/1994 Coll. on road traffic, as amended
regulations.
30) Act No. 506/1990 Coll., on weights and measures, as amended.
Decree No 345/2002 Coll., which provides for the gauge to a compulsory
authentication and gauges subject to type-approval.
31) § 79 paragraph 2. 7 of law No 378/2007 Sb.
32), for example, Act No. 18/1997 Coll., as amended,
Decree No 307/2002 Coll., as amended, Decree No.
49/1993 Coll., on technical and material requirements for equipment
medical devices, as amended, Decree No.
318/2002 Coll., on details to ensure emergency preparedness
nuclear facilities and workplaces with sources of ionizing radiation and
the requirements for the contents of the internal emergency plan and emergency procedure, in
amended by Decree No. 2/2004 Sb.
33) Act No. 258/2000 Coll., on the protection of public health and amending
some related laws, as amended.
34) Decree No. 537/2006 Coll., on inoculation against infectious diseases.
35) § 5 para. 8 of law No 378/2007 Sb.
36) Decree No 325/2003 Coll., laying down rules for the application of
medicinal products in providing veterinary care, including
related prescription and dispensing of medicinal products and the requirements for
keeping a record of those activities, and requirements for notification of the loading
with some substances or preparations, including the conditions for the management and
keeping a record of these activities.
37) Decree No 226/2008 Coll., on good clinical practice and detailed
the conditions of the clinical evaluation of drugs.